# FDA Inspection 1308792 - Jubilant DraxImage Inc., dba Jubilant Radiopharma - March 23, 2026

Source: https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/30cde839-f0c5-4e2e-8665-b804efa6e542
Source feed: FDA_Inspections

> FDA Inspection 1308792 for Jubilant DraxImage Inc., dba Jubilant Radiopharma on March 23, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1308792
- Company Name: Jubilant DraxImage Inc., dba Jubilant Radiopharma
- Inspection Date: 2026-03-23
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Orleans District Office

## Related Documents

- [FDA Inspection 984555 - 2016-09-13](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/1e489d0a-b5b9-44df-a2f4-657425e8570b)
- [FDA Inspection 827247 - 2013-04-12](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/08330115-3fbd-4b5d-b366-883af9c72cc9)

Company: https://www.keypedia.com/companies/jubilant-draximage-inc-dba-jubilant-radiopharma/e93ebd53-d49f-4ec4-8e7f-e24361a47374

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea